Cooling blood detoxification Decoction prevention randomized controlled trials of radiation pneumonitis.docVIP

 PAGE \* MERGEFORMAT 18 Cooling blood detoxification Decoction prevention randomized controlled trials of radiation pneumonitis Of: XIAO Chun, Ding Huijuan, Fenglin Chun, Lam music, ever since sinus [Abstract] Background: The breast cancer radiation pneumonitis, radiation therapy is the most common complication of patients with serious impact on quality of life, even life-threatening. There is no effective treatment to prevent Chinese or Western occurrence of radiation pneumonitis. Objective: Decoction observed cooling blood detoxification clinical efficacy of prevention of radiation pneumonitis. design, setting, participants and interventions: a prospective randomized controlled design. the People’s Liberation Army General Hospital Department of Radiation Oncology to determine the need for radiation therapy of 100 cases of lung cancer patients were randomly divided into treatment group and the control group, 50 patients in each group. the control group received radiotherapy alone, while the treatment group during radiotherapy Decoction Oral cooling blood detoxification. course of treatment, 3 patients off treatment group, excluding 1 case, the control group falling in 6 cases, removed 2 cases. Main outcome: To compare the incidence of radiation pneumonitis and radiation therapy with the American Cancer Cooperative Group (Radiation Therapy Oncology Group, RTOG acute radiation injury grading standards, clinical imaging physiological scoring system (clinical radiographic physiologic score system, CRP, physical condition Scale (Karnofsky Performance Status Scale, KPS assessment. Results: The incidence of radiation pneumonitis in the treatment group was 13.04% and 33.33% in control group, the two groups, the difference was statistically significant (P lt;0.05, according to RTOG classification standard treatment group, level of radiation lung injury in patients with pneumonia was significantly lower than the control group (P lt;0.05, CRP treatment group scores